Poniard Pharmaceuticals to Present at the BIO CEO & Investor Conference

Wednesday, February 4, 2009 General News J E 4
SOUTH SAN FRANCISCO, Calif., Feb. 3 PoniardPharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused oninnovative oncology therapies, today announced that Jerry McMahon, Ph.D.,chairman and CEO, will present at the 11th Annual BIO CEO & InvestorConference 2009 on Tuesday, February 10, at 10 a.m. Eastern Time at theWaldorf-Astoria in New York.

Dr. McMahon will provide a corporate overview, including a discussion ofthe clinical development program for picoplatin, the Company's lead productcandidate.

A live audio webcast of the presentation will be available for 10 businessdays on the "Events" page of the "News & Events" section of the Company'swebsite at

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc., is a biopharmaceutical company focused onthe development and commercialization of innovative oncology products toimpact the lives of people with cancer. Picoplatin, the Company's leadplatform product candidate, is a new generation platinum chemotherapy. Todate, clinical studies suggest that picoplatin has an improved safety profilerelative to existing platinum-based cancer therapies. Picoplatin is designedto overcome platinum resistance associated with chemotherapy in solid tumors,and is being studied in multiple cancer indications, combinations andformulations. Clinical trials of intravenous picoplatin include a Phase 3trial in small cell lung cancer and Phase 2 trials in metastatic colorectaland castration resistant prostate cancers (also known as hormone refractoryprostate cancer), as well as a clinical trial of oral picoplatin in solidtumors. For additional information please visit

(C) 2009 Poniard Pharmaceuticals, Inc. All Rights Reserved.

Poniard and Poniard Pharmaceuticals are trademarks of PoniardPharmaceuticals, Inc.

SOURCE Poniard Pharmaceuticals, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Guys, Breathe Easy - New Survey Suggests Women May...
National Wear Red Day - Feb. 6